This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of November 20, 2024, and a ceiling value of $2,627.89. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This is an unrestricted, non-set-aside contract, indicating Dakota Drug, Inc.'s competitive standing in the federal marketplace. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which further demonstrates its role as a key strategic supplier for the Defense Logistics Agency's medical supply chain needs.
Generated 2/18/25, 1:35 PM